<bill session="117" type="h" number="5435" updated="2023-03-09T17:47:08Z">
  <state datetime="2021-09-30">REFERRED</state>
  <status>
    <introduced datetime="2021-09-30"/>
  </status>
  <introduced datetime="2021-09-30"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a Neuroscience Translation Working Group, and for other purposes.</title>
    <title type="display">BRAIN Act of 2021</title>
    <title type="short" as="introduced">BRAIN Act of 2021</title>
    <title type="short" as="introduced">Bringing Regulatory Advances Into Neuroscience Act of 2021</title>
  </titles>
  <sponsor bioguide_id="B000574"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2021-09-30"/>
    <cosponsor bioguide_id="C001080" joined="2022-01-20"/>
    <cosponsor bioguide_id="F000466" joined="2021-12-09"/>
    <cosponsor bioguide_id="K000381" joined="2022-01-20"/>
    <cosponsor bioguide_id="P000096" joined="2021-09-30"/>
    <cosponsor bioguide_id="T000469" joined="2022-02-02"/>
  </cosponsors>
  <actions>
    <action datetime="2021-09-30">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-09-30">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1050"/>
    </action>
    <action datetime="2021-09-30" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-10-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug therapy"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Medical research"/>
    <term name="Neurological disorders"/>
    <term name="Scientific communication"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-15T18:30:39Z" status="Introduced in House">Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021

This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.

The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.

The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.</summary>
</bill>
